AI assistant
Sending…
AGENUS INC — Director's Dealing 2010
Jun 15, 2010
34023_dirs_2010-06-15_72c64b4e-604f-4f86-b491-f0e2931e1f6f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANTIGENICS INC /DE/ (AGEN)
CIK: 0001098972
Period of Report: 2010-06-14
Reporting Person: JORDAN WADIH (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-06-14 | Stock Option (right to buy) | $0.95 | A | 15000 | Acquired | 2020-06-14 | Common Stock (15000) | Direct |
Footnotes
F1: Options vest in three equal annual installments beginning June 14, 2011.
More from AGENUS INC
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Proxy Solicitation & Information Statement
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 9
Director's Dealing
2026
Jan 26
Major Shareholding Notification
2026
Jan 23